0001171843-19-000438.txt : 20190123 0001171843-19-000438.hdr.sgml : 20190123 20190123161947 ACCESSION NUMBER: 0001171843-19-000438 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190118 FILED AS OF DATE: 20190123 DATE AS OF CHANGE: 20190123 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Kowalsky Matthew Paul CENTRAL INDEX KEY: 0001705824 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36694 FILM NUMBER: 19537629 MAIL ADDRESS: STREET 1: 28 SEVINOR RD CITY: MARBLEHEAD STATE: MA ZIP: 01945 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PROTEON THERAPEUTICS INC CENTRAL INDEX KEY: 0001359931 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 781-890-0102 MAIL ADDRESS: STREET 1: 200 WEST STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 ownership.xml X0306 4 2019-01-18 0 0001359931 PROTEON THERAPEUTICS INC PRTO 0001705824 Kowalsky Matthew Paul C/O PROTEON THERAPEUTICS, INC. 200 WEST STREET WALTHAM MA 02451 0 1 0 0 VP, Legal and Secretary Stock Option (Right to Buy) 2.64 2019-01-18 4 A 0 60000 0 A 2029-01-17 Common Stock, $0.001 par value 60000 60000 D The options were granted on January 18, 2019 and the shares underlying this option vest 25% on the first anniversary of the grant date and the remaining shares vest in twelve equal quarterly installments. /s/ George A. Eldridge, attorney-in-fact 2019-01-23